Vanishing pulmonary hypertension in mixed connective tissue disease

Clinical Rheumatology

Volumn 18, Issue 1, 1999, Pages 45-47

  Lahaye, I E E ^a,b   Rogiers, P E M ^a   Nagler, J M ^a   Chappel, R ^a  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b Palmenlaan 55 ^*  (Belgium)

Author keywords

Mixed connective tissue disease; Nitric oxide ventilation; Plasmaexchange plasmapheresis; Pulmonary hypertension

Indexed keywords

CORTICOSTEROID; INOTROPIC AGENT; NITRIC OXIDE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; CARDIOPULMONARY ARREST; CASE REPORT; ECHOCARDIOGRAPHY; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INHALATIONAL DRUG ADMINISTRATION; MIXED CONNECTIVE TISSUE DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESUSCITATION;

ADMINISTRATION, INHALATION; ADULT; CARDIOPULMONARY RESUSCITATION; CARDIOTONIC AGENTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEART ARREST; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; MIXED CONNECTIVE TISSUE DISEASE; NITRIC OXIDE; PLASMA EXCHANGE; PULMONARY WEDGE PRESSURE; VASODILATOR AGENTS;

EID: 0032966007     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050051     Document Type: Article

References (13)

1. Alpert MA, Goldberg SH, Singsen BH, Durham JB, et al. Cardiovascular manifesations of mixed connective tissue disease in adults. Circulation 1983;68:1182-93.
2. Myles PS, Hall JL, Berry CB, Esmore DS. Primary pulmonary hypertension: prolonged cardiac arrest and successful resuscitation following induction of anaesthesia for heart-lung transplantation. J Cardiothorac Vasc Anesth 1994;8:678-81.
3. Martens P, Mullie A, Vandekerckhove, Aufierio TX, Chambers CE. Emergency use of cardiopulmonary bypass for resuscitation from CPR-resistant cardiac arrest. J Cardiothorac Vasc Anesth 1993;7:227-35.
4. Wiener-Kronisch JP, Sollinger AM, Warnock ,ML et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981;124:499-503.
5. Hosoda Y, Suzuki Y, Takano M, et al. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol 1987;14:826-30.
6. Martyn JB; Wong JW; Huang SHK: Pulmonary and neuromuscular complications of mixed connective tissue disease: a report and review of the literature. J Rheumatol 1988;15:703-5.
7. Dahl M.; Chalmers A.; Wade J.; Calverley D.; Munt B.: Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy. J Rheumatol 1992;19:1807-9.
8. Scully RE, Mark EJ, McNeely WF, McNeely BU. Case records of the Massachussetts General Hospital. Case 24-1995. A 46-year-old woman with dermatomyositis, increasing pulmonary insufficiency, and terminal right ventricular failure. N Engl J Med 1995;33:369-77.
9. Jolliet P, Thorens JB, Chevrolet JC. Pulmonary vascular reactivity in severe pulmonary hypertension associated with mixed connective tissue disease. Thorax 1995;50:96-7.
10. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991;338:1173-4.
11. Edmonds JP, Hughes GRV. Subclinical involvement and serological abnormalities in minimal lupus. Proceedings of the VIII European Rheumatology Congress, Helsinki. Scan J Rheumatol 1975;8:42.
12. Crapper RM, Dowling JP, Mackay IR, Whitworth JA. Acute sclerodermia in stable mixed connective tissue disease: treatment by plasmapheresis. Aust NZ J Med 1987;17:327-9.
13. Fletchner KM, Baum K. Mixed connective tissue disease: recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatment with plasmapheresis. J Neurol Sci 1994;126:146-8.